Natera Announces Medicare Coverage for Signatera™ Genome
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Business Wire
Broad coverage, inclusive of all previously covered Signatera indications AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its genome-based Signatera MRD assay is now covered by Medicare under LCD L38779.This coverage decision applies to Medicare beneficiaries with colorectal cancer, breast cancer, bladder cancer, ovarian cancer, lung cancer, and pan-cancer immunotherapy monitoring, mirroring the pre-existing coverage for Signatera.The coverage determination was supported by robust evidence on the validity of the genome-based assay, leveraging the extensive body of literature validating Signatera in over 100 published clinical studies.Earlier this week at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Natera presented a pan-cancer study of 392 patients (over 2,600 samples) using Signatera Genome. The assay was launched recently for both research and clinical use. It leve
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal CancerBusiness Wire
- Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD [Yahoo! Finance]Yahoo! Finance
- Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRDBusiness Wire
- Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target [Yahoo! Finance]Yahoo! Finance
- Is Labcorp Holdings Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
NTRA
Earnings
- 5/8/25 - Beat
NTRA
Sec Filings
- 7/3/25 - Form 4
- 7/3/25 - Form 4
- 7/3/25 - Form 4
- NTRA's page on the SEC website